Douglas J. Barrett | Academic Influence

Douglas J. Barrett's AcademicInfluence.com Rankings

Douglas J. Barrett

Computer Science

#11137

World Rank

#11766

Historical Rank

#1941

USA Rank

Machine Learning

#5767

World Rank

#5850

Historical Rank

#253

USA Rank

Artificial Intelligence

#6221

World Rank

#6325

Historical Rank

#366

USA Rank

Database

#9631

World Rank

#10173

Historical Rank

#1383

USA Rank

computer-science Degrees

Download Badge

Computer Science

Douglas J. Barrett's Degrees

Masters Computer Science Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Douglas J. Barrett Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Douglas John Barrett is the former Senior Vice President for the J. Hillis Miller Health Science Center at the University of Florida. He held the position from 2002 to 2009. As the Senior Vice President, he was responsible for an $850 million budget. He is a member of the American Board of Pediatrics and was the Vice Chairman of the Shands Health Care Board of Directors.

(See a Problem?)

Douglas J. Barrett's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

IgG2 subclass restriction of antibody to pneumococcal polysaccharides. (1986) (261)
Association of class II human histocompatibility leukocyte antigens with rheumatic fever. (1986) (170)
The DiGeorge syndrome and the fetal alcohol syndrome. (1982) (110)
Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. (1994) (80)
Spectrum of Sjögren syndrome in children. (1981) (71)
Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. (1993) (70)
Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo (1993) (69)
Clinical and immunologic spectrum of the DiGeorge syndrome. (1981) (67)
Immunoglobulin G and M antibodies to pneumococcal polysaccharides detected by enzyme-linked immunosorbent assay (1980) (54)
IgG and IgM Pneumococcal Polysaccharide Antibody Responses in Infants (1984) (43)
Thymosin therapy in the DiGeorge syndrome. (1980) (39)
Pediatric Hospital Medicine: A Proposed New Subspecialty (2017) (37)
Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. (1985) (35)
Group A Streptococcal Antibodies in Subjects with or without Rheumatic Fever in Areas with High or Low Incidences of Rheumatic Fever (2003) (32)
Aging and the Immune Response to Tetanus Toxoid: Diminished Frequency and Level of Cellular Immune Reactivity to Antigenic Stimulation (1998) (32)
IN VITRO AND IN VIVO ENHANCEMENT OF MIXED LYMPHOCYTE CULTURE REACTIVITY BY THYMOSIN IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE (1979) (32)
Arrested rearrangement of TCR V beta genes in thymocytes from children with X-linked severe combined immunodeficiency disease. (1994) (31)
T lymphocyte depletion of human peripheral blood and bone marrow using monoclonal antibodies and magnetic microspheres. (1987) (27)
The evolving organizational structure of academic health centers: the case of the University of Florida. (2008) (27)
Immunoregulation in aged humans. (1980) (25)
Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiency. (1984) (25)
Immunological applications of type III Fc binding proteins. Comparison of different sources of protein G. (1989) (24)
Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. (1988) (24)
Human anti-pneumococcal polysaccharide antibodies are secreted by the CD5- B cell lineage. (1992) (24)
Cell-mediated immunity in the newborn: clinical aspects. (1979) (23)
Inhibition of human lymphocyte activation by wheat germ agglutinin: a model for saccharide-specific suppressor factors. (1983) (22)
Increased T lymphocytes bearing the gamma-delta T cell receptor in subjects at high risk for insulin dependent diabetes. (1991) (20)
The Temporal Association Between γδ T Cells and the Natural History of Insulin-Dependent Diabetes (1993) (20)
Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response. (1981) (20)
Con A-induced suppressor cell function depends on the activation of the CD4+CD45RA inducer T cell subpopulation. (1991) (19)
Defective inducer T-cell function before the onset of insulin-dependent diabetes mellitus. (1991) (18)
Prevalence of T-lymphocyte abnormalities in infants with congenital heart disease. (1984) (16)
Combined immunodeficiency due to the selective absence of CD4 inducer T lymphocytes. (1990) (14)
Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay (1983) (13)
Infants with meningitis without cerebrospinal fluid pleocytosis. (1986) (13)
Pneumococcal polysaccharide immunization in patients with active nephrotic syndrome. (1988) (11)
Evolution of the subclass of IgG antibody to type 3 pneumococcal polysaccharide during childhood. (1987) (9)
CD5+ B Lymphocytes in High-Risk Islet Cell Antibody–Positive and Newly Diagnosed IDDM Subjects (1991) (9)
The temporal association between gamma delta T cells and the natural history of insulin-dependent diabetes. (1993) (8)
Immunization Of The Immunocompromised Host (1998) (7)
Long-term immunoregulatory effects of therapy with corticosteroids and anti-thymocyte globulin. (1989) (6)
Familial DiGeorge syndrome with tetralogy of Fallot and prolonged survival (2004) (5)
CHAPTER 24 – Lymphocyte stimulation by bacterial Fc receptors (1990) (4)
Helper cell function of human fetal thymocytes. (1981) (4)
Milk precipitins in selective IgA deficiency. (1979) (3)
PNEUMOCOCCAL TYPE 3 ANTIBODY IS RESTRICTED TO THE IgG2 SUBCLASS (1984) (2)
T-CELL INDEPENDENT HUMAN PNEUMOCOCCAL POLYSACCHARIDE SYNTHESIS (1984) (1)
Characterization of the acquired immune deficiency syndrome at the cellular and molecular level (1984) (1)
Thymosin and the spontaneously diabetic BB rat. (1988) (1)
The prophetic fount: the ideal of abundance and Milton's recovery of paradise (2000) (0)
Excellence in teaching: what does it cost? How can we pay for it? (2002) (0)
88 PREDNISONE/AZATHIOPRINE IMMUNOSUPPRESSIVE THERAPY FOR INSULIN DEPENDENT DIABETES (IDD) (1985) (0)
898 SUPPRESSOR/HELPER CELL FUNCTION IN CHILDREN WITH AUTOIMMUNE DISEASE (1981) (0)
ONTOGENY OF THE SUBCLASS OF ANTIBODY TO PNEUMOCOCCAL POLYSACCHARIDE TYPE 3 (1987) (0)
Activation and differentiation of human lymphocytes by bacterial Fc-binding proteins (1990) (0)
1599 PNEUMOCOCCAL VACCINATION IN PATIENTS WITH ACTIVE NEPHROTIC SYNDROME (NS) (1985) (0)
Immunoregulatory CD4 + T Cell Subpopulations: Enumeration, Activation, and Functional Analyses in Normals and Autoimmune Disease (1990) (0)
ONTOGENY OF HUMAN CD4 LYMPHOCYTE SUBPOPULATIONS FOLLOWING BONE MARROW TRANSPLANTATION (1987) (0)
897 PNEUMOCOCCAL VACCINE (PnVx) IN SICKLE CELL DISEASE (SCD): IgG AND IgM ANTIBODY RESPONSE (1981) (0)
RESIDENCY TRAINING FOR TODAY ’ S HOSPITALIZED PATIENTS Overview of Current Pediatric Residency Training (2017) (0)
899 IMMUNODEFICIENCY IN CONGENITAL HEART DISEASE (CHD) (1981) (0)
HAPLOIDENTICAL BONE MARROW TRANSPLANTATION OF CHILDREN WITH X-LINKED SCID USING BONE MARROW DEPLETED OF T-CELLS BY CENTRIFUGAL ELUTRIATION. •69 (1996) (0)
CONCANAVALIN A ACTIVATES THE SUPPRESSOR/INDUCER SUBPOPULATION OF CD4+ T LYMPHOCYTES (1987) (0)

This paper list is powered by the following services:

Other Resources About Douglas J. Barrett

en.wikipedia.org

What Schools Are Affiliated With Douglas J. Barrett?

Douglas J. Barrett is affiliated with the following schools: